Logo image of ALGEV.PA

GEVELOT SA (ALGEV.PA) Stock Fundamental Analysis

EPA:ALGEV - Euronext Paris - Matif - FR0000033888 - Common Stock - Currency: EUR

190  -1 (-0.52%)

Fundamental Rating

6

Taking everything into account, ALGEV scores 6 out of 10 in our fundamental rating. ALGEV was compared to 104 industry peers in the Machinery industry. Both the health and profitability get an excellent rating, making ALGEV a very profitable company, without any liquidiy or solvency issues. ALGEV has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

ALGEV had positive earnings in the past year.
In the past year ALGEV had a positive cash flow from operations.
Each year in the past 5 years ALGEV has been profitable.
Of the past 5 years ALGEV 4 years had a positive operating cash flow.
ALGEV.PA Yearly Net Income VS EBIT VS OCF VS FCFALGEV.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10M -10M 20M

1.2 Ratios

ALGEV has a better Return On Assets (4.21%) than 65.38% of its industry peers.
ALGEV has a Return On Equity (6.10%) which is in line with its industry peers.
ALGEV's Return On Invested Capital of 4.66% is in line compared to the rest of the industry. ALGEV outperforms 42.31% of its industry peers.
The Average Return On Invested Capital over the past 3 years for ALGEV is below the industry average of 8.40%.
The last Return On Invested Capital (4.66%) for ALGEV is above the 3 year average (3.97%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 4.21%
ROE 6.1%
ROIC 4.66%
ROA(3y)3.1%
ROA(5y)2.51%
ROE(3y)4.49%
ROE(5y)3.67%
ROIC(3y)3.97%
ROIC(5y)3.3%
ALGEV.PA Yearly ROA, ROE, ROICALGEV.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 2 4 6 8

1.3 Margins

ALGEV has a Profit Margin of 8.76%. This is amongst the best in the industry. ALGEV outperforms 88.46% of its industry peers.
ALGEV's Profit Margin has improved in the last couple of years.
ALGEV has a better Operating Margin (8.45%) than 70.19% of its industry peers.
ALGEV's Operating Margin has improved in the last couple of years.
With an excellent Gross Margin value of 64.83%, ALGEV belongs to the best of the industry, outperforming 93.27% of the companies in the same industry.
ALGEV's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 8.45%
PM (TTM) 8.76%
GM 64.83%
OM growth 3Y31.37%
OM growth 5Y1.64%
PM growth 3Y100.32%
PM growth 5Y6.66%
GM growth 3Y-0.71%
GM growth 5Y-0.38%
ALGEV.PA Yearly Profit, Operating, Gross MarginsALGEV.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 40 60

9

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ALGEV is destroying value.
ALGEV has less shares outstanding than it did 1 year ago.
The number of shares outstanding for ALGEV has been reduced compared to 5 years ago.
The debt/assets ratio for ALGEV has been reduced compared to a year ago.
ALGEV.PA Yearly Shares OutstandingALGEV.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 200K 400K 600K 800K
ALGEV.PA Yearly Total Debt VS Total AssetsALGEV.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M

2.2 Solvency

ALGEV has an Altman-Z score of 3.00. This indicates that ALGEV is financially healthy and has little risk of bankruptcy at the moment.
With a decent Altman-Z score value of 3.00, ALGEV is doing good in the industry, outperforming 76.92% of the companies in the same industry.
The Debt to FCF ratio of ALGEV is 1.77, which is an excellent value as it means it would take ALGEV, only 1.77 years of fcf income to pay off all of its debts.
With an excellent Debt to FCF ratio value of 1.77, ALGEV belongs to the best of the industry, outperforming 88.46% of the companies in the same industry.
A Debt/Equity ratio of 0.02 indicates that ALGEV is not too dependend on debt financing.
ALGEV has a Debt to Equity ratio of 0.02. This is amongst the best in the industry. ALGEV outperforms 96.15% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF 1.77
Altman-Z 3
ROIC/WACC0.6
WACC7.8%
ALGEV.PA Yearly LT Debt VS Equity VS FCFALGEV.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50M 100M 150M 200M

2.3 Liquidity

ALGEV has a Current Ratio of 3.04. This indicates that ALGEV is financially healthy and has no problem in meeting its short term obligations.
ALGEV's Current ratio of 3.04 is amongst the best of the industry. ALGEV outperforms 89.42% of its industry peers.
ALGEV has a Quick Ratio of 2.43. This indicates that ALGEV is financially healthy and has no problem in meeting its short term obligations.
With an excellent Quick ratio value of 2.43, ALGEV belongs to the best of the industry, outperforming 92.31% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.04
Quick Ratio 2.43
ALGEV.PA Yearly Current Assets VS Current LiabilitesALGEV.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M 250M

3

3. Growth

3.1 Past

The earnings per share for ALGEV have decreased strongly by -18.83% in the last year.
The Earnings Per Share has been growing by 18.17% on average over the past years. This is quite good.
Looking at the last year, ALGEV shows a decrease in Revenue. The Revenue has decreased by -2.87% in the last year.
ALGEV shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 9.93% yearly.
EPS 1Y (TTM)-18.83%
EPS 3Y140.12%
EPS 5Y18.17%
EPS Q2Q%-31.84%
Revenue 1Y (TTM)-2.87%
Revenue growth 3Y19.1%
Revenue growth 5Y9.93%
Sales Q2Q%-8.86%

3.2 Future

Based on estimates for the next years, ALGEV will show a very negative growth in Earnings Per Share. The EPS will decrease by -12.21% on average per year.
ALGEV is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 0.98% yearly.
EPS Next Y-25.57%
EPS Next 2Y-12.21%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-1.03%
Revenue Next 2Y0.98%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ALGEV.PA Yearly Revenue VS EstimatesALGEV.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M
ALGEV.PA Yearly EPS VS EstimatesALGEV.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2 4 6 8 10

4

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 13.09, ALGEV is valued correctly.
Compared to the rest of the industry, the Price/Earnings ratio of ALGEV indicates a somewhat cheap valuation: ALGEV is cheaper than 73.08% of the companies listed in the same industry.
When comparing the Price/Earnings ratio of ALGEV to the average of the S&P500 Index (29.35), we can say ALGEV is valued rather cheaply.
Based on the Price/Forward Earnings ratio of 14.04, the valuation of ALGEV can be described as correct.
The rest of the industry has a similar Price/Forward Earnings ratio as ALGEV.
ALGEV's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 22.10.
Industry RankSector Rank
PE 13.09
Fwd PE 14.04
ALGEV.PA Price Earnings VS Forward Price EarningsALGEV.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

65.38% of the companies in the same industry are more expensive than ALGEV, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, ALGEV is valued a bit more expensive than the industry average as 61.54% of the companies are valued more cheaply.
Industry RankSector Rank
P/FCF 41.23
EV/EBITDA 6.38
ALGEV.PA Per share dataALGEV.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 50 100 150 200 250

4.3 Compensation for Growth

The decent profitability rating of ALGEV may justify a higher PE ratio.
A cheap valuation may be justified as ALGEV's earnings are expected to decrease with -12.21% in the coming years.
PEG (NY)N/A
PEG (5Y)0.72
EPS Next 2Y-12.21%
EPS Next 3YN/A

5

5. Dividend

5.1 Amount

ALGEV has a Yearly Dividend Yield of 2.62%. Purely for dividend investing, there may be better candidates out there.
ALGEV's Dividend Yield is a higher than the industry average which is at 2.63.
Compared to an average S&P500 Dividend Yield of 2.33, ALGEV has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.62%

5.2 History

The dividend of ALGEV is nicely growing with an annual growth rate of 17.90%!
Dividend Growth(5Y)17.9%
Div Incr Years4
Div Non Decr Years4
ALGEV.PA Yearly Dividends per shareALGEV.PA Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 1 2 3 4

5.3 Sustainability

22.70% of the earnings are spent on dividend by ALGEV. This is a low number and sustainable payout ratio.
DP22.7%
EPS Next 2Y-12.21%
EPS Next 3YN/A
ALGEV.PA Yearly Income VS Free CF VS DividendALGEV.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10M -10M 20M
ALGEV.PA Dividend Payout.ALGEV.PA Dividend Payout, showing the Payout Ratio.ALGEV.PA Dividend Payout.PayoutRetained Earnings

GEVELOT SA

EPA:ALGEV (3/7/2025, 7:00:00 PM)

190

-1 (-0.52%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners1.21%
Inst Owner ChangeN/A
Ins Owners7.72%
Ins Owner ChangeN/A
Market Cap142.50M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.62%
Yearly Dividend3.98
Dividend Growth(5Y)17.9%
DP22.7%
Div Incr Years4
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 13.09
Fwd PE 14.04
P/S 0.94
P/FCF 41.23
P/OCF 16.08
P/B 0.66
P/tB 0.67
EV/EBITDA 6.38
EPS(TTM)14.52
EY7.64%
EPS(NY)13.53
Fwd EY7.12%
FCF(TTM)4.61
FCFY2.43%
OCF(TTM)11.82
OCFY6.22%
SpS201.65
BVpS289.85
TBVpS285.51
PEG (NY)N/A
PEG (5Y)0.72
Profitability
Industry RankSector Rank
ROA 4.21%
ROE 6.1%
ROCE 5.57%
ROIC 4.66%
ROICexc 5.19%
ROICexgc 5.28%
OM 8.45%
PM (TTM) 8.76%
GM 64.83%
FCFM 2.29%
ROA(3y)3.1%
ROA(5y)2.51%
ROE(3y)4.49%
ROE(5y)3.67%
ROIC(3y)3.97%
ROIC(5y)3.3%
ROICexc(3y)5.48%
ROICexc(5y)5.34%
ROICexgc(3y)5.61%
ROICexgc(5y)5.66%
ROCE(3y)4.75%
ROCE(5y)3.95%
ROICexcg growth 3Y26.48%
ROICexcg growth 5Y-0.9%
ROICexc growth 3Y27.25%
ROICexc growth 5Y-0.71%
OM growth 3Y31.37%
OM growth 5Y1.64%
PM growth 3Y100.32%
PM growth 5Y6.66%
GM growth 3Y-0.71%
GM growth 5Y-0.38%
F-Score7
Asset Turnover0.48
Health
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF 1.77
Debt/EBITDA 0.23
Cap/Depr 79.26%
Cap/Sales 3.57%
Interest Coverage 250
Cash Conversion 45.21%
Profit Quality 26.08%
Current Ratio 3.04
Quick Ratio 2.43
Altman-Z 3
F-Score7
WACC7.8%
ROIC/WACC0.6
Cap/Depr(3y)159.97%
Cap/Depr(5y)116.02%
Cap/Sales(3y)7.77%
Cap/Sales(5y)6.04%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-18.83%
EPS 3Y140.12%
EPS 5Y18.17%
EPS Q2Q%-31.84%
EPS Next Y-25.57%
EPS Next 2Y-12.21%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-2.87%
Revenue growth 3Y19.1%
Revenue growth 5Y9.93%
Sales Q2Q%-8.86%
Revenue Next Year-1.03%
Revenue Next 2Y0.98%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y7.71%
EBIT growth 3Y56.46%
EBIT growth 5Y11.73%
EBIT Next Year31.12%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y129.6%
FCF growth 3YN/A
FCF growth 5Y-24.95%
OCF growth 1Y568.39%
OCF growth 3Y53.99%
OCF growth 5Y-11.86%